1.290USD0.00%Mkt Cap: 3.70M USDP/E: 0.73Last update: 2026-06-01
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and in…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap3.70M USD
Enterprise Value-59.57K USD
Revenue (TTM)142.00K USD
Gross Profit139.00K USD
Net Income (TTM)-2.49M USD
Revenue/Share0.0610 USD
Last Price1.290 USD
Fiscal Year EndMar 2025
MR QuarterDec 2025
Employees14
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)0.73
P/E (Forward)—
PEG—
EV/EBITDA0.01
EV/Revenue-0.42
P/S26.70
P/B0.77
EPS (TTM)1.76
EPS (Forward)—
52W Range
1.2202% of range5.300
52W High5.300 USD
52W Low1.220 USD
Profitability
Gross Margin96.53%
Oper. Margin-10576.92%
EBITDA Margin0.00%
Profit Margin-1727.78%
ROE-23.71%
ROA-16.98%
Growth
Revenue Growth8.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.46M USD
CapEx (TTM)13.00K USD
FCF Margin-5560.48%
FCF Yield-213.11%
Net Debt-3.48M USD
Net Debt/EBITDA0.31
Balance Sheet
Debt/Equity0.09
Current Ratio2.44
Quick Ratio1.75
Book Value/Sh1.703 USD
Cash/Share1.644 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateAug 19, 2020
Splits
Last Split1:12
Split DateMar 21, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.2.89M
Float2.33M
Insiders13.08%
Institutions7.81%
Short Interest
Short Ratio0.9d
Short % Float1.41%
Short % Out.1.39%
Shares Short40.28K
Short (prev mo.)27.97K
Technical
SMA 501.469 (-12.2%)
SMA 2002.128 (-39.4%)
Beta1.41
S&P 52W Chg27.70%
Avg Vol (30d)49.27K
Avg Vol (10d)49.10K
Technical Indicators
RSI (14)38.0
MACD-0.0569
MACD Signal-0.0635
MACD Hist.+0.0066
BB Upper1.453 USD
BB Middle1.340 USD
BB Lower1.226 USD
BB Width16.91%
ATR (14)0.0857 USD
Vol Ratio (20d)1.32x